Workflow
大豆颗粒蛋白
icon
Search documents
索宝蛋白跌5.22% 2023年上市超募4.2亿元
Zhong Guo Jing Ji Wang· 2026-02-12 09:14
Group 1 - The core viewpoint of the article highlights that Suobao Protein (603231.SH) is currently trading at 18.70 yuan, reflecting a decline of 5.22% and is in a state of breaking its initial public offering price [1] - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with a total issuance of 47.8648 million shares at an initial price of 21.29 yuan per share, with no existing shares being transferred [1] - The total funds raised from the initial public offering amounted to 1,019.0416 million yuan, with a net amount of 979.4557 million yuan, exceeding the original plan by 424.8731 million yuan [1] Group 2 - The company plans to use the raised funds of 554.5826 million yuan for the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [1] - The total issuance costs for the public offering were 39.5859 million yuan (excluding tax), with underwriting and sponsorship fees amounting to 27.3585 million yuan [1]
索宝蛋白跌1.03% 2023年上市超募4.2亿元
Zhong Guo Jing Ji Wang· 2026-02-03 08:33
Core Viewpoint - The stock of Suobao Protein (603231.SH) is currently trading at 19.17 yuan, reflecting a decline of 1.03% and is in a state of underperformance since its IPO [1] Group 1: IPO Details - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with a total issuance of 47.86 million shares, all being new shares without any existing shares being transferred [1] - The IPO price was set at 21.29 yuan per share, and the total funds raised amounted to 1.019 billion yuan, with a net amount of 979.46 million yuan after expenses [1] - The final net fundraising exceeded the original plan by 424.87 million yuan, indicating strong investor interest [1] Group 2: Fund Utilization - The company plans to utilize the raised funds for several projects, including a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, and a 75-ton medium-temperature and medium-pressure efficient coal powder boiler project, as well as for working capital [1] Group 3: Underwriting and Fees - The total issuance costs for the public offering amounted to 39.59 million yuan (excluding tax), with underwriting and sponsorship fees accounting for 27.36 million yuan [1]
破发股索宝蛋白股东拟减持 2023年上市超募4.2亿元
Zhong Guo Jing Ji Wang· 2025-04-23 05:58
Group 1 - Shanghai Bunge plans to reduce its stake in Suobao Protein by up to 5,743,615 shares, representing no more than 3% of the total share capital [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 1,914,500 shares (1% of total share capital) through centralized bidding and 3,829,115 shares (2% of total share capital) through block trading [1] - As of the announcement date, Shanghai Bunge holds 7,179,715 shares, accounting for 3.75% of the total share capital, all of which were acquired before the company's IPO [1] Group 2 - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with an issuance of 47,864,800 shares at a price of 21.29 yuan per share, raising a total of 1,019.04 million yuan [2] - The net proceeds from the offering amounted to 979.46 million yuan, exceeding the original plan by 424.87 million yuan [2] - The funds raised will be allocated to the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [2]